Tango Therapeutics, Inc. TNGX
- vopimetostat — Pancreatic Cancer Phase 1
- vopimetostat — Non-Small Cell Lung Cancer Phase 1
- TNG456 — Glioblastoma Phase 1
- vopimetostat Phase 1
PRMT5 (1 companies · 4 programs)
Companies with an active program directed at PRMT5.